MeConcord: a new metric to quantitatively characterize DNA methylation heterogeneity across reads and CpG sites
MOTIVATION: Intermediately methylated regions occupy a significant fraction of the human genome and are closely associated with epigenetic regulations or cell-type deconvolution of bulk data. However, these regions show distinct methylation patterns, corresponding to different biological mechanisms....
Main Authors: | Wang, X. (Author), Zhang, X. (Author) |
---|---|
Format: | Article |
Language: | English |
Published: |
NLM (Medline)
2022
|
Online Access: | View Fulltext in Publisher |
Similar Items
-
Targeted methylation at CpG sites on DNA
by: McNamara, Andrew Raeburn
Published: (2002) -
DNA and chromatin binding by the methyl-CpG-binding protein, MeCP2
by: Goddard, C.
Published: (2003) -
The CpG island methylator phenotype is concordant between primary colorectal carcinoma and matched distant metastases
by: Stacey A. Cohen, et al.
Published: (2017-05-01) -
Prediction of CpG Sites Methylation Status in Human Genome
by: Wei-li Liao, et al.
Published: (2008) -
Expression of the methyl-CpG-binding protein MeCP2 in rat brain. An ontogenetic study
by: Suzanne Cassel, et al.
Published: (2004-03-01)